OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study
Anna Olewicz‐Gawlik, Barbara Ginter-Matuszewska, Mikołaj Kamiński, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 107-107
Open Access | Times Cited: 5
Anna Olewicz‐Gawlik, Barbara Ginter-Matuszewska, Mikołaj Kamiński, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 107-107
Open Access | Times Cited: 5
Showing 5 citing articles:
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
Wiktor Schmidt, Katarzyna Pawlak‐Buś, Barbara Jóźwiak, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2429-2429
Open Access | Times Cited: 3
Wiktor Schmidt, Katarzyna Pawlak‐Buś, Barbara Jóźwiak, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2429-2429
Open Access | Times Cited: 3
Inflammatory Markers for Prognosis of COVID-19 Mortality in Hospitalized Indian Patients: A Single-Center Retrospective Study
Nuha Al-Aghbari, Arif Maldar, Mubashir Angolkar, et al.
University of Science and Technology Journal for Medical Sciences (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Nuha Al-Aghbari, Arif Maldar, Mubashir Angolkar, et al.
University of Science and Technology Journal for Medical Sciences (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Efficacy of tocilizumab in treatment of COVID-19 pneumonia
Minal Shastri, Darshankumar Manubhai Raval, Ummayhany Bharmal, et al.
Lung India (2022) Vol. 39, Iss. 6, pp. 510-516
Open Access | Times Cited: 1
Minal Shastri, Darshankumar Manubhai Raval, Ummayhany Bharmal, et al.
Lung India (2022) Vol. 39, Iss. 6, pp. 510-516
Open Access | Times Cited: 1
Trending Proinflammatory Markers to Prognosticate Mechanical Ventilation in COVID-19
Paul T. Kozak, Sophia M. Koziol, Andrew Mariano, et al.
Infectious Diseases in Clinical Practice (2023) Vol. 31, Iss. 2
Closed Access
Paul T. Kozak, Sophia M. Koziol, Andrew Mariano, et al.
Infectious Diseases in Clinical Practice (2023) Vol. 31, Iss. 2
Closed Access
“Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital”
Sachinkumar Dole, M.S. Barthwal, CB Ashwin Ramesh, et al.
Lung India (2023) Vol. 40, Iss. 3, pp. 299-300
Open Access
Sachinkumar Dole, M.S. Barthwal, CB Ashwin Ramesh, et al.
Lung India (2023) Vol. 40, Iss. 3, pp. 299-300
Open Access
